Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

ClinicalTrials.gov 24,857 recruiting now free trial finder

Find a clinical trial that's recruiting now

Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.

24,857
trials recruiting now
14%
of all US trials open to enrollment
52
states with recruiting sites

A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.

50 trials found

RECRUITING NA 200 target

E3 Hypertension - A Team-based, Multidisciplinary Model in Addressing Barriers to Hypertension Control

Rush University Medical Center

This study aims to compare a multidisciplinary clinical hypertension and social needs intervention to enhanced standard of care for hypertension management in primary care clinics with regards to hypertension control outcomes.

NCT06899750

RECRUITING NA 30 target

Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System

Aria CV

This prospective study is a multi-center early feasibility study assessing the safety and performance of the Aria CV Pulmonary Hypertension System in patients with pulmonary hypertension and right heart dysfunction.

NCT04555161

COMPLETED NA 140 target

Staying Healthy After Childbirth: My Hypertension Education and Reaching Target Program for Postpartum

University of Wisconsin, Madison

A study of Staying Healthy After Childbirth (STAC) and My Hypertension Education And Reaching Target (MyHEART) for postpartum (p) patients to determine if health coaching can increase 12-month postpartum care attendance...

NCT05685251

ACTIVE NOT RECRUITING 100 target

Trans-pulmonary Biomarkers in Pulmonary Hypertension

Vanderbilt University

The investigators are testing whether the addition of Pulmonary Hypertension-related biomarkers, measured across the pulmonary circulation, to the standard hemodynamic evaluation for Pulmonary Hypertension will lead to more informed choices of...

NCT01961232

COMPLETED NA 160 target

Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes

US Department of Veterans Affairs

To determine racial/ethnic differences in preference for group visits in veterans with poorly controlled hypertension (State 2 hypertension) and determine the effect of group visits on health outcomes among veterans with...

NCT00439816

COMPLETED Phase 4 20 target

Inhaled Iloprost for Sarcoidosis-associated Pulmonary Hypertension

University of Cincinnati

This trial will study the treatment of sarcoidosis-associated pulmonary arterial hypertension with inhaled iloprost, a drug approved for primary pulmonary arterial hypertension.

NCT00403650

COMPLETED NA 122 target

ADAPT-Altering Diet for African American Populations to Treat Hypertension

University of Alabama at Birmingham

...intervention and test the effectiveness of the intervention lower blood pressure in a group of African American participants at risk for developing hypertension (pre-hypertension) and those with mild hypertension (stage I).

NCT00621569

COMPLETED Phase 3 4 target

Treatment of Masked Hypertension

University of Minnesota

To date, most observational and all intervention studies have defined hypertension on the basis of clinic blood pressure (BP). Measurement of BP outside the clinic with home or ambulatory BP provides a...

NCT02142881

COMPLETED NA 300 target

Group Visits to Improve Hypertension Management

US Department of Veterans Affairs

This study investigates group medical visits as a quality improvement strategy for hypertension. It studies group visits in which patients see their own primary care provider together with other patients who have...

NCT00129493

COMPLETED NA 1,300 target

Improving Practice Patterns for the Treatment of Hypertension

US Department of Veterans Affairs

To improve the quality of hypertension care in our facility, while concurrently, examining the relative contribution of each aspect of a multi-factorial intervention designed to improve hypertension care.

NCT00265044

RECRUITING NA 12 target

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Vanderbilt University Medical Center

Supine hypertension is a common problem that affects at least 50% of patients with primary autonomic failure. Supine hypertension can be severe and complicates the treatment of orthostatic hypotension. The purpose of...

NCT03312556

COMPLETED 24 target

Hypertension and Sleep Disordered Breathing in Pediatrics

NYU Langone Health

The primary objective is to determine the prevalence of sleep disordered breathing in children with primary hypertension or pre hypertension. The secondary objectives are to determine any association factors for children with...

NCT00990899

COMPLETED Phase 2 12 target

Tadalafil for Sarcoidosis Associated Pulmonary Hypertension

University of North Carolina, Chapel Hill

This study is designed to assess safety and efficacy of tadalafil in patients with Sarcoidosis Associated Pulmonary Hypertension. Hypothesis: Tadalafil is safe and effective in treating pulmonary hypertension in patients with Sarcoidosis

NCT01324999

TERMINATED 490 target

Early, Simple and Reliable Detection of Pulmonary Arterial Hypertension (PAH) in Systemic Sclerosis (SSc)

Actelion

A two-stage prospective observational cohort study in scleroderma patients to evaluate screening tests and the incidence of pulmonary arterial hypertension and pulmonary hypertension

NCT00706082

COMPLETED 602 target

Multi-center, Web Based Observational Study of Pulmonary Hypertension in Scleroderma Patients

Georgetown University

The purpose of this study is to determine the timeline of progression from pre-pulmonary hypertension to diagnosable pulmonary hypertension based on right heart catheterization. Moreover, to determine the timeline for progression...

NCT00377949

COMPLETED 43 target

Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension

University of Colorado, Denver

This study plans to learn more about activity levels in children with pulmonary hypertension. Pulmonary hypertension is a condition where the pressure in the lungs is higher than normal. This can affect...

NCT04745000

COMPLETED 12 target

Epigenomic Dysregulation in Preeclampsia-Associated Chronic Hypertension

Ohio State University

...It is unknown whether aberrant DNA methylation in pregnancy-induced hypertension is the mechanism by which chronic hypertension develops in these women remote from pregnancy nor is it known if hypertension remote...

NCT01682304

COMPLETED 19 target

Effects of Pulmonary Hypertension Therapy in Atypical Pulmonary Arterial Hypertension

Mayo Clinic

The purpose of this study is to characterize the clinical and hemodynamic response of Pulmonary Arterial Hypertension (PAH) therapy in patients with atypical PAH and risk factors for left heart disease.

NCT04787445

ACTIVE NOT RECRUITING NA 37 target

Investigating Behavior Change Methods for the Management of Hypertension

Texas A&M University

This project aims to promote general wellness using a mobile health intervention that incorporates health coaching to help manage hypertension. The mobile application (HyperCoach) does not intend to cure, mitigate, or prevent...

NCT07631546

TERMINATED 179 target

Pediatric Hypertension Registry (PHREG)

Wake Forest University Health Sciences

Pediatric hypertension is increasingly common and is a precursor for adult cardiovascular and renal disease. But even during childhood, hypertension is associated with significant morbidity, including cognitive impairment and organ damage. However...

NCT03305562

COMPLETED NA 17 target

A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension

University of North Carolina, Chapel Hill

The purpose of this study is to investigate the effect of plasma renin activity-guided therapy for determining hypertension treatment. Plasma renin is an enzyme in your blood that can be measured...

NCT01658657

COMPLETED NA 159 target

Achieving Blood Pressure Control Together Study

Johns Hopkins University

African Americans represent a particularly vulnerable subgroup of persons with hypertension, as they are more likely than Whites to have hypertension, equally as likely to be aware of it and to be...

NCT01902719

COMPLETED NA 20 target

Telemedicine Management of Hypertension

Wake Forest University Health Sciences

Explore barriers, facilitators, acceptability, feasibility, and fidelity of the telemedicine management of hypertension intervention

NCT05424744

TERMINATED Phase 2 10 target

A Study in Participants With Sarcoidosis-associated Pulmonary Hypertension (SAPH) to Assess the Efficacy and Safety of Oral Selexipag

Actelion

Oral selexipag is commercially available in several countries for the treatment of a particular group of pulmonary hypertension (PH) called pulmonary arterial hypertension (PAH). The aim of the present study is to...

NCT03942211

COMPLETED NA 9 target

Spinal Cord Stimulation to Treat Hypertension

University of Minnesota

To investigate the exercise blood pressure response during a lower-extremity dynamic exercise in postmenopausal women with hypertension and to determine if lumbar epidural spinal cord stimulation reduces blood pressure during exercise...

NCT02828436

COMPLETED Phase 2 195 target

A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

AstraZeneca

This study will evaluate the efficacy and safety of CIN-107 for the treatment of hypertension in patients with uncontrolled hypertension (uHTN) and Chronic Kidney Disease (CKD).

NCT05432167

RECRUITING 2,500 target

Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry

New York Medical College

Patients are being asked to be in this research study because medical researchers hope that by gathering information about a large number of children with pulmonary hypertension over time, their understanding of...

NCT02249923

ACTIVE NOT RECRUITING NA 150 target

Groceries for Black Residents of Boston to Stop Hypertension Among Adults With Treated Hypertension

Beth Israel Deaconess Medical Center

GoFreshRx is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults actively treated for hypertension, residing in Boston area urban food...

NCT05393232

TERMINATED Phase 2 50 target

Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)

Yale University

To determine if low dose aspirin reduces the incidence of hypertensive disorders of pregnancy (gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome) in pregnant women with stage 1 hypertension and elevated blood pressure.

NCT04402385

TERMINATED NA 69 target

Using Lay Health Advisors to Improve Hypertension Management

MetroHealth Medical Center

...The investigators propose to determine the impact of using trained lay health advisors to help patients address social contextual factors that influence the management of hypertension.

NCT03515005

RECRUITING Phase 3 487 target

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1

Eli Lilly and Company

GZL1 is an independent study conducted under the GZPL master protocol. GZL1 will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.

NCT06948435

TERMINATED 2 target

Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)

Inova Health Care Services

The purpose of this study is to determine whether pulmonary arterial hypertension can worsen or even cause sleep apnea. It is hypothesized that if pulmonary arterial hypertension does indeed worsen or cause...

NCT01835080

RECRUITING 300 target

Pulmonary Hypertension Biorepository and Registry

University of Kansas Medical Center

Establish a pulmonary hypertension registry and biorepository to lead towards a further understanding of the disease.

NCT04808596

TERMINATED Early Phase 1 28 target

Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

Yale University

Women with androgen excess polycystic ovary syndrome (AE-PCOS) leads to hypertension.

NCT04327934

TERMINATED Phase 3 453 target

Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide

The University of Texas Medical Branch, Galveston

Postpartum prophylactic HCTZ administration for prevention and relapse of preeclampsia or gestational hypertension.

NCT03298802

RECRUITING Phase 3 487 target

A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2

Eli Lilly and Company

GZL2 is an independent study conducted under the GZPL master protocol. GZL2 study will evaluate the efficacy and safety of orforglipron for treatment of hypertension in participants with obesity or overweight.

NCT06952530

TERMINATED Phase 4 10 target

Acute Control of Chronic Hypertension

Albany Medical College

The purpose of this study is to understand if administration of a personalized dose of the anti-hypertensive medication, labetalol, based on patient's history of preexisting hypertension, will be more effective...

NCT03877692

COMPLETED NA 60 target

Improving Hypertension Control

Medical College of Wisconsin

* The overall hypothesis for the project is that racial health disparities will be reduced by improving hypertension control in African Americans. * This will be accomplished through the development, implementation, and evaluation of...

NCT01910857

COMPLETED Phase 2 16 target

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension

Medical University of South Carolina

Hypothesis: Ambrisentan (Letairis ®) is safe and effective in treating pulmonary hypertension in patients with Sarcoidosis

NCT00851929

RECRUITING 354 target

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer

National Cancer Institute (NCI)

This research trial studies whole exome sequencing in finding causative variants in germline deoxyribonucleic acid (DNA) samples from patients with hypertension receiving bevacizumab for breast cancer. Studying samples of germline DNA in...

NCT02610413

COMPLETED Phase 3 796 target

A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant Hypertension

AstraZeneca

...720 participants aged ≥ 18 years with hypertension, despite a stable regimen of 2 antihypertensive agents at baseline, one of which is a diuretic (uncontrolled hypertension); or ≥ 3 antihypertensive agents at baseline, one...

NCT06034743

COMPLETED NA 60 target

A COmmunity and Tech-Based ApproaCh for Hypertension Self-MANagement

Case Western Reserve University

The prevalence of hypertension among U.S. adults increased from 32% to 46% and African Americans are disproportionately impacted. Self-managing hypertension presents challenges such as dealing with complex treatment regimen, including...

NCT03724487

RECRUITING Phase 1 70 target

Targeting Endoplasmic Reticulum Stress in Human Hypertension

University of North Texas Health Science Center

There is strong evidence suggesting that endoplasmic reticulum stress contributes to neurogenic and vascular hypertension in various animal models, however this has never been explored in humans. Therefore, this project will fill...

NCT06025630

COMPLETED Phase 3 190 target

Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation

US Department of Veterans Affairs

Clinical trial of implementation of clinical practice guidelines for managing hypertension in primary care clinics.

NCT00122161

COMPLETED NA 84 target

The Hypotensive Effects of Home-Based Isometric Handgrip Training in Older Adults With Pre-Hypertension and Hypertension - The HoldAge Trial

University Institute of Maia

New data suggests that isometric handgrip training (IHT) might become a novel tool in the treatment of hypertension. The main purpose of this research project is to evaluate the effects of home...

NCT04275037

TERMINATED 1,000 target

Hypertension in Management of Military Medicine

United States Naval Medical Center, San Diego

This study is a retrospective database review of primary care appointments of patients' charts with new diagnoses of hypertension.

NCT00134849

COMPLETED NA 171 target

Community Health Workers Using Patient Stories to Support Hypertension Management

University of Massachusetts, Worcester

Community Health Workers (CHWs) using patient stories to support hypertension management is a randomized controlled trial to evaluate the implementation of a CHW-delivered culturally appropriate storytelling intervention for english and spanish...

NCT02874547

COMPLETED 365 target

Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension

University of California, San Francisco

The purpose of this study is to describe the epidemiology of pulmonary hypertension in individuals with HIV infection and to investigate its pathogenesis. We propose to conduct a prospective observational cohort study...

NCT00845013

TERMINATED Phase 3 422 target

A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents

Pfizer

The primary purpose of this study is to evaluate the blood pressure lowering effects of ramipril, an FDA-approved drug for the treatment of hypertension in adults, in children and adolescents aged...

NCT00389519

COMPLETED Phase 4 85 target

PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial

Actelion

24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.

NCT02382016

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.

Verify with NIH →